SERA Sera Prognostics, Inc.

NASDAQ
$1.81

Sera Prognostics, Inc. (SERA) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.5% since its last earnings release on November 4, 2026.

Sera Prognostics Missed Consensus Estimates
Wednesday, November 4, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.14)
Rev est $100K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.04

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sera Prognostics, Inc.

Sera Prognostics is a leading health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.